COMMUNIQUÉS West-GlobeNewswire

Notification from Oasmia Pharmaceutical AB
26/03/2019
Notification from Oasmia Pharmaceutical AB Uppsala, Sweden, March 26, 2019 – The Swedish Securities Council has today published a statement regarding Oasmia. For statement please click here (only in Swedish). About [...]
Matinas BioPharma to Announce Full-Year 2018 Operational and Financial Results on April 2, 2019
26/03/2019
Conference call and live audio webcast on Tuesday, April 2nd at 8:00 a.m. ET BEDMINSTER, N.J., March 26, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical [...]
Blissco Signs Agreement to Supply New Brunswick with Premium Cannabis
26/03/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, March 26, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Predictive Technology Group Completes Acquisition of Taueret Laboratories
26/03/2019
Addition of CAP/CLIA laboratory and experienced diagnostics team form an unparalleled molecular clinical and research facility to accelerate new product development, commercialization and scale SALT LAKE CITY, March 26 [...]
iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit
26/03/2019
NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief [...]
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
26/03/2019
Phase 1b SLE top-line data and Phase 2 LN initiation in Q2 2019 Phase 2 trials in up to four additional autoimmune indications to begin 2H 2019 First clinical candidate nomination for protein secretion program in 2019 [...]
Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference
26/03/2019
MALVERN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Aura Announces Appointment of Alain Dobkin to its Board of Directors
26/03/2019
TORONTO, March 26, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the appointment of Alain Dobkin to its board of directors, subject to regulatory approval. [...]
D.A. Wallach Joins BioSig Technologies Advisory Board
26/03/2019
Successful business leader to support Company’s business development Santa Monica, CA, March 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary [...]
MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences
26/03/2019
TORONTO, March 26, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
BeyondSpring’s Lead Asset, Plinabulin, Shifts the Balance of Macrophages Towards Anti-Cancer M1s
26/03/2019
Promising New Immuno-Oncology Component to Plinabulin’s Mechanism-of-Action to be Presented at 2019 American Association for Cancer Research Annual Meeting NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results
26/03/2019
NEWTOWN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Immunotherapy Company Enlivex Therapeutics Announces Nasdaq Listing Under Symbol “ENLV” and Closing of Private Placement of Ordinary Shares Priced at $12.25 Per Share
26/03/2019
Nes Ziona, Israel, March 26, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced its Nasdaq listing under the symbol “ENLV” and the concurrent [...]
Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery
26/03/2019
Patent provides coverage for lipid-nanoparticle delivery of encapsulated mRNA where the encoded protein or peptide is secreted LEXINGTON, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a [...]
ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019
26/03/2019
Company to showcase innovative programs addressing urgent need for disease-modifying therapies selectively targeting toxic oligomers in Alzheimer’s and Parkinson’s diseases and ALS TORONTO and CAMBRIDGE, Mass., March 26 [...]
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
26/03/2019
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND (Investigational New Drug [...]
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
26/03/2019
Study is part of clinical trial collaboration with Pfizer SOUTH SAN FRANCISCO, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on [...]
Rhizen Pharmaceuticals S.A. announces poster presentation of RP4010, a calcium release-activated calcium (CRAC) channel inhibitor in preclinical models of Gastrointestinal (GI) Cancers at the 2019 AACR Annual Meeting
26/03/2019
La Chaux-de-Fonds, Switzerland, March 26, 2019 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announces poster presentation of RP4010, a novel first-in-class CRAC channel inhibitor in preclinical models of [...]
Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Pages